Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan McIntyre

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Infection Control and Hospital Epidemiology|February 14, 2014
Selecting an antiretroviral regimen for human immunodeficiency virus postexposure prophylaxis in the occupational settingDarrell H S Tan, Blessing Goddey-Erikefe, Deborah Yoong, et al.
Clinical Biochemistry|September 23, 2010
Pediatric reference intervals for lymphocyte vitamin C (ascorbic acid)Alex Levin, Charmaine DeSouza, Christian Zaarour, et al.
Cancer|October 21, 2010
Prognostic factors for survival in melanoma patients with brain metastasesMichael A Davies, Ping Liu, Susan McIntyre, et al.
Journal of Immunotoxicology|June 24, 2008
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survivalAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
Melanoma Research|December 3, 2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaChan Yoon, Nicholas E Papadopoulos, Luis H Camacho, et al.
Cancer Investigation|June 28, 2008
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanomaAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
Emerging Infectious Diseases|December 23, 2014
Hospital-associated transmission of Brucella melitensis outside the laboratoryChristopher F Lowe, Adrienne J Showler, Suzette Perera, et al.
American Journal of Clinical Oncology|December 15, 2010
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanomaAgop Y Bedikian, Caimiao Wei, Michelle Detry, et al.
Melanoma Research|November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
JACC. Cardiovascular Imaging|March 14, 2016
The Authors ReplyRichard Lorber, Shubhika Srivastava, Travis J Wilder, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Infection Control and Hospital Epidemiology|February 14, 2014
Selecting an antiretroviral regimen for human immunodeficiency virus postexposure prophylaxis in the occupational settingDarrell H S Tan, Blessing Goddey-Erikefe, Deborah Yoong, et al.
Clinical Biochemistry|September 23, 2010
Pediatric reference intervals for lymphocyte vitamin C (ascorbic acid)Alex Levin, Charmaine DeSouza, Christian Zaarour, et al.
Cancer|October 21, 2010
Prognostic factors for survival in melanoma patients with brain metastasesMichael A Davies, Ping Liu, Susan McIntyre, et al.
Journal of Immunotoxicology|June 24, 2008
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survivalAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
Melanoma Research|December 3, 2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaChan Yoon, Nicholas E Papadopoulos, Luis H Camacho, et al.
Cancer Investigation|June 28, 2008
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanomaAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
Emerging Infectious Diseases|December 23, 2014
Hospital-associated transmission of Brucella melitensis outside the laboratoryChristopher F Lowe, Adrienne J Showler, Suzette Perera, et al.
American Journal of Clinical Oncology|December 15, 2010
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanomaAgop Y Bedikian, Caimiao Wei, Michelle Detry, et al.
Melanoma Research|November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
JACC. Cardiovascular Imaging|March 14, 2016
The Authors ReplyRichard Lorber, Shubhika Srivastava, Travis J Wilder, et al.
Pageof 3